{"id":"https://openalex.org/W4281992279","doi":"https://doi.org/10.2337/db22-337-or","title":"337-OR: Tirzepatide Improved Markers of Islet-Cell Function (Fasting Glucagon and HOMA2-B) and Insulin Sensitivity (Fasting Insulin and HOMA2-IR) Compared with Semaglutide in People with Type 2 Diabetes","display_name":"337-OR: Tirzepatide Improved Markers of Islet-Cell Function (Fasting Glucagon and HOMA2-B) and Insulin Sensitivity (Fasting Insulin and HOMA2-IR) Compared with Semaglutide in People with Type 2 Diabetes","publication_year":2022,"publication_date":"2022-05-31","ids":{"openalex":"https://openalex.org/W4281992279","doi":"https://doi.org/10.2337/db22-337-or"},"language":"en","primary_location":{"id":"doi:10.2337/db22-337-or","doi":"https://doi.org/10.2337/db22-337-or","is_oa":false,"landing_page_url":"https://doi.org/10.2337/db22-337-or","pdf_url":null,"source":{"id":"https://openalex.org/S129060628","display_name":"Diabetes","issn_l":"0012-1797","issn":["0012-1797","1939-327X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5076645868","display_name":"KATELYN BROWN","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"KATELYN BROWN","raw_affiliation_strings":["Indianapolis, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Indianapolis, IN","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072715491","display_name":"Laura Fern\u00e1ndez Land\u00f3","orcid":"https://orcid.org/0000-0002-0969-6214","observed_orcids":["https://orcid.org/0000-0002-0969-6214"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"LAURA FERNANDEZ LANDO","raw_affiliation_strings":["Indianapolis, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Indianapolis, IN","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040651874","display_name":"Brandon K. Bergman","orcid":"https://orcid.org/0009-0006-3668-7686","observed_orcids":["https://orcid.org/0009-0006-3668-7686"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"BRANDON BERGMAN","raw_affiliation_strings":["Indianapolis, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Indianapolis, IN","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013110210","display_name":"Melissa K. Thomas","orcid":"https://orcid.org/0000-0001-9848-2834","observed_orcids":["https://orcid.org/0000-0001-9848-2834"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"MELISSA K. THOMAS","raw_affiliation_strings":["Indianapolis, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Indianapolis, IN","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"BING LIU","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"BING LIU","raw_affiliation_strings":["Indianapolis, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Indianapolis, IN","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5031509690","display_name":"Clare J. Lee","orcid":"https://orcid.org/0000-0002-0824-0207","observed_orcids":["https://orcid.org/0000-0002-0824-0207"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"CLARE LEE","raw_affiliation_strings":["Indianapolis, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Indianapolis, IN","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.6641,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.6583285,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"71","issue":"Supplement_1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10839","display_name":"Pancreatic function and diabetes","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tirzepatide","display_name":"tirzepatide","score":0.996999979019165},{"id":"https://openalex.org/keywords/semaglutide","display_name":"semaglutide","score":1.0},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9959999918937683},{"id":"https://openalex.org/keywords/islet-function","display_name":"islet function","score":0.7940000295639038},{"id":"https://openalex.org/keywords/insulin-sensitivity","display_name":"insulin sensitivity","score":0.765999972820282},{"id":"https://openalex.org/keywords/homa2-ir","display_name":"HOMA2-IR","score":0.7429999709129333},{"id":"https://openalex.org/keywords/homa2-b","display_name":"HOMA2-B","score":0.9520000219345093},{"id":"https://openalex.org/keywords/fasting-insulin","display_name":"fasting insulin","score":0.7789999842643738},{"id":"https://openalex.org/keywords/gip-glp-1-receptor-agonist","display_name":"GIP/GLP-1 receptor agonist","score":0.875},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.8849999904632568},{"id":"https://openalex.org/keywords/metformin","display_name":"metformin","score":0.6729999780654907},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.7480000257492065},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.7879999876022339},{"id":"https://openalex.org/keywords/c-peptide","display_name":"C-peptide","score":0.7839999794960022}],"concepts":[{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.804201602935791},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7851700782775879},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.7371693849563599},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.6299731135368347},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.6226816177368164},{"id":"https://openalex.org/C165220095","wikidata":"https://www.wikidata.org/wiki/Q207524","display_name":"Islet","level":3,"score":0.5838675498962402},{"id":"https://openalex.org/C2909862629","wikidata":"https://www.wikidata.org/wiki/Q27261089","display_name":"Semaglutide","level":5,"score":0.5109159350395203},{"id":"https://openalex.org/C3017594256","wikidata":"https://www.wikidata.org/wiki/Q1053470","display_name":"Insulin sensitivity","level":4,"score":0.49651771783828735},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.4911307990550995},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4590870141983032},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.45274290442466736},{"id":"https://openalex.org/C2777391703","wikidata":"https://www.wikidata.org/wiki/Q1053470","display_name":"Insulin resistance","level":3,"score":0.43568697571754456},{"id":"https://openalex.org/C2781308992","wikidata":"https://www.wikidata.org/wiki/Q2526479","display_name":"Liraglutide","level":4,"score":0.07054001092910767},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.2337/db22-337-or","doi":"https://doi.org/10.2337/db22-337-or","is_oa":false,"landing_page_url":"https://doi.org/10.2337/db22-337-or","pdf_url":null,"source":{"id":"https://openalex.org/S129060628","display_name":"Diabetes","issn_l":"0012-1797","issn":["0012-1797","1939-327X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4367674317","https://openalex.org/W4391091645","https://openalex.org/W2961575013","https://openalex.org/W4381376394","https://openalex.org/W4394936280","https://openalex.org/W4399690321","https://openalex.org/W4312214397","https://openalex.org/W4281717385","https://openalex.org/W4399032763","https://openalex.org/W3108676144"],"abstract_inverted_index":{"Tirzepatide":[0],"(TZP)":[1],"achieved":[2],"significantly":[3,114,165,188],"greater":[4],"HbA1c":[5,46],"and":[6,13,63,122,195,214,222,227,234,239,246,251,258,263,270,275,280],"weight":[7],"reductions":[8],"with":[9,29,87,99,104,120,127,150,158,171,181,206],"all":[10,81,172],"doses":[11,83,125,133,174],"(5,":[12],"15":[14,123],"mg)":[15],"vs.":[16],"semaglutide":[17],"1":[18],"mg":[19,124],"(SEMA)":[20],"in":[21,56,73,204],"a":[22,92,140,154],"Phase":[23],"3":[24],"trial":[25],"of":[26,59,147,179,191],"1879":[27],"people":[28,205],"type":[30],"2":[31],"diabetes":[32],"(T2D)":[33],"on":[34,97,118,145,169],"background":[35],"metformin":[36],"(mean":[37],"age":[38],"56.6":[39],"years;":[40,44],"T2D":[41],"duration":[42],"8.6":[43],"baseline":[45],"8.3%":[47],"[67":[48],"mmol/mol];":[49],"BMI":[50],"34.2":[51],"kg/m2)":[52],"(SURPASS-2)":[53],".":[54,130],"Changes":[55],"fasting":[57,111],"markers":[58,190],"islet":[60,192],"cell":[61,193],"function":[62,194],"insulin":[64,135,161,196],"sensitivity":[65,136,197],"were":[66,163],"assessed":[67],"by":[68,91,95,116,139,143,156,167],"mixed":[69],"model":[70],"repeated":[71],"measures":[72],"the":[74],"modified":[75],"intent-to-treat":[76],"population.":[77],"At":[78],"40":[79],"weeks,":[80],"TZP":[82,121,132,173,187],"improved":[84,134,189],"HOMA2-B,":[85],"calculated":[86,149],"C-peptide,":[88],"as":[89,137],"indicated":[90],"significant":[93,141],"increase":[94,178],"97-120%":[96],"average":[98,119,146,170],"TZP,":[100],"compared":[101,126,152,175,198],"to":[102,153,176,199],"84%":[103],"SEMA.":[105,159,182],"Fasting":[106,160],"glucagon":[107],"levels,":[108],"adjusted":[109],"for":[110],"serum":[112],"glucose,":[113],"decreased":[115],"53-55%":[117],"SEMA":[128,203],"(48%)":[129],"All":[131],"reflected":[138],"decrease":[142,155],"16-24%":[144],"HOMA2-IR,":[148],"insulin,":[151],"5%":[157],"levels":[162],"also":[164],"reduced":[166],"9-21%":[168],"an":[177],"0.6%":[180],"Dual":[183],"GIP/GLP-1":[184],"receptor":[185],"agonist":[186],"selective":[200],"GLP-1":[201],"RA":[202],"T2D.":[207],"Disclosure":[208],"K.":[209],"Brown:":[210],"Employee;":[211,219,231,243,255,267],"Eli":[212,220,225,232,237,244,249,256,261,268,273,278],"Lilly":[213,221,226,233,238,245,250,257,262,269,274,279],"Company.":[215,223,228,235,240,247,252,259,264,271,276],"L.":[216],"Fernandez":[217],"Lando:":[218],"Stock/Shareholder;":[224,236,248,260,272],"B.":[229,253],"Bergman:":[230],"M.K.":[241],"Thomas:":[242],"Liu:":[254],"C.":[265],"Lee:":[266],"Funding":[277],"Company":[281]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1}],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2022-06-13T00:00:00"}